Diagnos Inc.
DGNOF
$0.16
$0.002.17%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.02% | -22.92% | -37.82% | -47.09% | -32.65% |
| Total Depreciation and Amortization | 1.19% | 1.49% | -2.48% | -1.27% | 0.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.01% | -13.02% | 3.25% | 1.39% | 6.32% |
| Change in Net Operating Assets | 69.57% | 158.43% | -2,001.23% | 170.32% | -247.87% |
| Cash from Operations | -4.12% | -28.40% | -59.33% | -59.71% | -63.34% |
| Capital Expenditure | 20.20% | 19.79% | -29.11% | -78.87% | -22.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 151.34% | 94.60% | 208.16% | -385.26% | -58,907.89% |
| Cash from Investing | 150.76% | 94.22% | 206.68% | -371.35% | -18,826.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -145.22% | -558.99% | -576.50% | -549.62% | -185.95% |
| Issuance of Common Stock | -50.62% | -6.33% | -30.58% | 123.46% | 345.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.03% | 16.77% | 8.03% | 1.64% | -8.72% |
| Cash from Financing | -63.78% | -22.70% | -53.03% | 106.54% | 208.24% |
| Foreign Exchange rate Adjustments | 150.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 283.77% | 1,537.20% | -98.65% | 96.11% | -51.90% |